Product NDC: | 0615-0331 |
Proprietary Name: | hydroxyzine pamoate |
Non Proprietary Name: | hydroxyzine pamoate |
Active Ingredient(s): | 25 mg/1 & nbsp; hydroxyzine pamoate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0615-0331 |
Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087479 |
Marketing Category: | ANDA |
Start Marketing Date: | 19811214 |
Package NDC: | 0615-0331-39 |
Package Description: | 30 CAPSULE in 1 BLISTER PACK (0615-0331-39) |
NDC Code | 0615-0331-39 |
Proprietary Name | hydroxyzine pamoate |
Package Description | 30 CAPSULE in 1 BLISTER PACK (0615-0331-39) |
Product NDC | 0615-0331 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hydroxyzine pamoate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19811214 |
Marketing Category Name | ANDA |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | HYDROXYZINE PAMOATE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antihistamine [EPC],Histamine Receptor Antagonists [MoA] |